Creto-Provirion

BELIGAS PHARMACEUTICALS CRETO-PROVIRON

Creto-Provirion, a product of meticulous formulation by Beligas Pharmaceuticals, features Mesterolone as its active substance. It is designed to optimize androgen levels, contributing to a range of benefits for users.

DRUG COMPOSITION

Each Creto-Provirion tablet contains 10 mg of Mesterolone, ensuring precision in dosage for tailored results.

PHARMACEUTICAL FORM

Creto-Provirion is presented in oral tablet form, providing a convenient and efficient means of administration.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical Group: Androgens and Antiandrogens
ATC Code: G03BA02 (Mesterolone)

PHARMACOLOGICAL PROPERTIES

Mesterolone, the active compound in Creto-Provirion, exhibits potent androgenic properties. It functions by enhancing androgen receptor binding, promoting protein synthesis, and exerting anti-estrogenic effects.

PROFILE

• Chemical name: 1О±-Methyl-17ОІ-hydroxy-[5О±]-androstan-3-one
• Chemical formula: C20H32O2
• Percentage of anabolic activity: 150.00%
• Percentage of androgenic activity: 40.00%
• Active half life: 12 hours
• Recommended dosage: 25-100 mg/day
• Acne: yes
• Bloating (water retention): no
• HBR: no
• Hepatic toxicity: low
• Aromatization: no

THERAPEUTICAL INDICATIONS

Creto-Provirion is indicated for conditions requiring androgen support, including male hypogonadism and fertility disorders. It is also employed in the management of androgen deficiencies.

DOSES AND METHOD OF ADMINISTRATION

Dosage: Initiate with 25 mg to 50 mg daily for optimal results.
Administration: Orally, with or without food, for efficient absorption.

CYCLE/STACKING

Solo Cycle:

• Dosage: Begin with 25 mg daily.
• Cycle Length: 8-12 weeks.

Cutting Cycle:

• Stack with Anavar-Lite or Pro-Winstrol.
• Dosage: Adjust Creto-Provirion to 50 mg daily.
• Cycle Length: 6-8 weeks.

Bulking Cycle:

• Combine with Pro-Dynabol or Etho-Testosterone.
• Dosage: Adapt Creto-Provirion to 50-75 mg daily.
• Cycle Length: 8-10 weeks.

POST CYCLE THERAPY

Commence post-cycle therapy using compounds like Clomid or Nolvadex, starting 2-3 days after the last Creto-Provirion dose.

SIDE EFFECTS

Potential side effects may include androgenic effects such as acne and increased hair growth. However, Creto-Provirion is generally well-tolerated.

CONTRAINDICATIONS

Creto-Provirion is contraindicated in individuals with a history of hypersensitivity to Mesterolone or related components.

OVERDOSE

In case of overdose, seek immediate medical attention.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Regular monitoring of liver function is recommended during use. Caution in patients with pre-existing liver conditions.

INTERACTIONS WITH OTHER DRUGS

Creto-Provirion may interact with anticoagulants, insulin, and oral hypoglycemic agents. Consult a healthcare professional to manage potential interactions.

PRESENTATION, PACKAGING

10 mg per tablet, 50 tablets in bottle.

STORAGE

Store Creto-Provirion at room temperature, away from moisture and sunlight.

DELIVERY TO THE USA

Reliable and discreet delivery options to the USA are available. Please refer to the supplier for specific details.

LEGAL STATUS

Creto-Provirion is a prescription-only medication, and adherence to local regulations regarding purchase and use is obligatory.

Note: The information provided is for educational purposes only and does not substitute professional medical advice. Consult with a healthcare professional for personalized guidance on the use of Creto-Provirion.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Beligas Pharmaceuticals
USA

EXTERNAL LINKS

• Mesterolone Wiki, wikipedia.org
• Mesterolone | C20H32O2 | CID 15020, pubchem.ncbi.nlm.nih.gov.